CytomX Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2013 | — | — | $8.7M |
| FY2014 | $74.9M | $73.1M | $64.4M |
| FY2015 | $71.1M | $197.2M | $59.8M |
| FY2016 | $120.6M | $199.1M | $104.6M |
| FY2017 | $327.7M | $397.6M | $177.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2013 | — | — | $8.7M |
| FY2014 | $74.9M | $73.1M | $64.4M |
| FY2015 | $71.1M | $197.2M | $59.8M |
| FY2016 | $120.6M | $199.1M | $104.6M |
| FY2017 | $327.7M | $397.6M | $177.5M |